Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2012 4
2013 1
2014 1
2015 2
2017 1
2021 3
2022 2
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo - a commentary.
Zola Matuvanga T, Doshi RH, Muya A, Cikomola A, Milabyo A, Nasaka P, Mitashi P, Muhindo-Mavoko H, Ahuka S, Nzaji M, Hoff NA, Perry R, Mukamba Musenga E. Zola Matuvanga T, et al. Among authors: mitashi p. Hum Vaccin Immunother. 2022 Nov 30;18(6):2127272. doi: 10.1080/21645515.2022.2127272. Epub 2022 Sep 27. Hum Vaccin Immunother. 2022. PMID: 36165731 Free PMC article.
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Zola Matuvanga T, Larivière Y, Lemey G, De Bie J, Milolo S, Meta R, Esanga E, Vermeiren PP, Thys S, Van Geertruyden JP, Van Damme P, Maketa V, Matangila J, Mitashi P, Muhindo-Mavoko H. Zola Matuvanga T, et al. Among authors: mitashi p. Vaccine. 2022 May 31;40(25):3470-3480. doi: 10.1016/j.vaccine.2022.04.094. Epub 2022 May 9. Vaccine. 2022. PMID: 35550847 Free article.
Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.
Zola Matuvanga T, Mariën J, Larivière Y, Osang'ir BI, Milolo S, Meta R, Esanga E, Maketa V, Matangila J, Mitashi P, Ahuka Mundeke S, Muhindo-Mavoko H, Muyembe Tamfum JJ, Van Damme P, Van Geertruyden JP. Zola Matuvanga T, et al. Among authors: mitashi p. PLoS One. 2023 Sep 1;18(9):e0286479. doi: 10.1371/journal.pone.0286479. eCollection 2023. PLoS One. 2023. PMID: 37656725 Free PMC article.
Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.
Larivière Y, Zola T, Stoppie E, Maketa V, Matangila J, Mitashi P, De Bie J, Muhindo-Mavoko H, Van Geertruyden JP, Van Damme P. Larivière Y, et al. Among authors: mitashi p. BMJ Open. 2021 Sep 28;11(9):e046835. doi: 10.1136/bmjopen-2020-046835. BMJ Open. 2021. PMID: 34588237 Free PMC article.
Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo.
Lemey G, Larivière Y, Zola TM, Maketa V, Matangila J, Mitashi P, Vermeiren P, Thys S, De Bie J, Muhindo HM, Ravinetto R, Van Damme P, Van Geertruyden JP. Lemey G, et al. Among authors: mitashi p. BMJ Glob Health. 2021 Jun;6(6):e005726. doi: 10.1136/bmjgh-2021-005726. BMJ Glob Health. 2021. PMID: 34183329 Free PMC article.
Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study.
Zola Matuvanga T, Johnson G, Larivière Y, Esanga Longomo E, Matangila J, Maketa V, Lapika B, Mitashi P, Mc Kenna P, De Bie J, Van Geertruyden JP, Van Damme P, Muhindo Mavoko H. Zola Matuvanga T, et al. Among authors: mitashi p. J Med Internet Res. 2021 Aug 9;23(8):e28573. doi: 10.2196/28573. J Med Internet Res. 2021. PMID: 34378545 Free PMC article. Clinical Trial.
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
Matangila JR, Doua JY, Mitashi P, da Luz RI, Lutumba P, Van Geertruyden JP. Matangila JR, et al. Among authors: mitashi p. Int J Antimicrob Agents. 2017 Mar;49(3):339-347. doi: 10.1016/j.ijantimicag.2016.11.017. Epub 2017 Jan 17. Int J Antimicrob Agents. 2017. PMID: 28108368 Clinical Trial.
22 results